203 related articles for article (PubMed ID: 32321335)
1. Soluble TREM-1 Levels in Familial Mediterranean Fever Related AA-Amyloidosis.
Ugurlu S; Egeli BH; Bolayirli IM; Ozdogan H
Immunol Invest; 2021 Feb; 50(2-3):273-281. PubMed ID: 32321335
[No Abstract] [Full Text] [Related]
2. In familial Mediterranean fever, soluble TREM-1 plasma level is higher in case of amyloidosis.
Gorlier C; Sellam J; Laurans L; Simon T; Giurgea I; Bastard JP; Fellahi S; Deshayes S; Grateau G; Ait Oufella H; Georgin-Lavialle S
Innate Immun; 2019 Nov; 25(8):487-490. PubMed ID: 31474164
[TBL] [Abstract][Full Text] [Related]
3. The role of azurocidin in patients with familial Mediterranean fever and AA amyloidosis and its association with cardiovascular risk factors.
Bozaci I; Tatar E
Int Urol Nephrol; 2021 Mar; 53(3):531-538. PubMed ID: 33058037
[TBL] [Abstract][Full Text] [Related]
4. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
Sahin S; Sahin GM; Ergin H; Kantarci G
Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
Varan Ö; Kucuk H; Babaoglu H; Guven SC; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
[TBL] [Abstract][Full Text] [Related]
6. Secondary bladder amyloidosis with familial Mediterranean fever in a living donor kidney transplant recipient: a case report.
Imamura S; Narita S; Nishikomori R; Tsuruta H; Numakura K; Maeno A; Saito M; Inoue T; Tsuchiya N; Nanjo H; Heike T; Satoh S; Habuchi T
BMC Res Notes; 2016 Oct; 9(1):473. PubMed ID: 27760547
[TBL] [Abstract][Full Text] [Related]
7. Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever.
Ugurlu S; Hacioglu A; Adibnia Y; Hamuryudan V; Ozdogan H
Orphanet J Rare Dis; 2017 May; 12(1):105. PubMed ID: 28558744
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Mean Platelet Volume in Patients with AA Amyloidosis and AA Amyloidosis Secondary to Familial Mediterranean Fever: A Retrospective Chart - Review Study.
Bakan A; Oral A; Alışır Ecder S; Şaşak Kuzgun G; Elçioğlu ÖC; Demirci R; Aydın Bahat K; Odabas AR
Med Sci Monit; 2019 May; 25():3854-3859. PubMed ID: 31123243
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment with humanized anti-interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever.
Hamanoue S; Suwabe T; Hoshino J; Sumida K; Mise K; Hayami N; Sawa N; Takaichi K; Fujii T; Ohashi K; Yazaki M; Ikeda S; Ubara Y
Mod Rheumatol; 2016 Jul; 26(4):610-3. PubMed ID: 25619282
[TBL] [Abstract][Full Text] [Related]
10. Familial Mediterranean fever (FMF) with proteinuria: clinical features, histology, predictors, and prognosis in a cohort of 25 patients.
Kukuy O; Livneh A; Ben-David A; Kopolovic J; Volkov A; Shinar Y; Holtzman E; Dinour D; Ben-Zvi I
J Rheumatol; 2013 Dec; 40(12):2083-7. PubMed ID: 24128782
[TBL] [Abstract][Full Text] [Related]
11. Continuous ambulatory peritoneal dialysis in familial Mediterranean fever amyloidosis patients with end-stage renal failure: a single-centre experience from Turkey.
Altiparmak MR; Pamuk ON; Ataman R; Serdengeçti K
Nephron Clin Pract; 2004; 98(4):c119-23. PubMed ID: 15627789
[TBL] [Abstract][Full Text] [Related]
12. Specific changes in faecal microbiota are associated with familial Mediterranean fever.
Deshayes S; Fellahi S; Bastard JP; Launay JM; Callebert J; Fraisse T; Buob D; Boffa JJ; Giurgea I; Dupont C; Jegou S; Straube M; Karras A; Aouba A; Grateau G; Sokol H; Georgin-Lavialle S; ;
Ann Rheum Dis; 2019 Oct; 78(10):1398-1404. PubMed ID: 31377728
[TBL] [Abstract][Full Text] [Related]
13. Role of fecal calprotectin in the assessment of intestinal inflammation in children with familial Mediterranean fever.
Gucenmez OA; Kume T; Makay B; Babayigit O; Arslan N; Unsal E
Int J Rheum Dis; 2018 Oct; 21(10):1844-1848. PubMed ID: 30345692
[TBL] [Abstract][Full Text] [Related]
14. Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure.
Stankovic Stojanovic K; Delmas Y; Torres PU; Peltier J; Pelle G; Jéru I; Colombat M; Grateau G
Nephrol Dial Transplant; 2012 May; 27(5):1898-901. PubMed ID: 21931121
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the mean platelet volume in secondary amyloidosis due to familial Mediterranean fever.
Ozkayar N; Piskinpasa S; Akyel F; Dede F; Yildirim T; Turgut D; Koc E; Haznedaroglu IC
Rheumatol Int; 2013 Oct; 33(10):2555-9. PubMed ID: 23673449
[TBL] [Abstract][Full Text] [Related]
16. Cystatin C in serum as an early marker of renal involvement in Familial Mediterranean Fever patients.
Deveci K; Gokakin AK; Senel S; Deveci H; Uslu AU; Sancakdar E
Eur Rev Med Pharmacol Sci; 2013 Jan; 17(2):253-60. PubMed ID: 23377817
[TBL] [Abstract][Full Text] [Related]
17. Serum galectin-3 levels were associated with proteinuria in patients with Familial Mediterranean Fever.
Yilmaz H; Inan O; Darcin T; Bilgic MA; Akcay A
Clin Exp Nephrol; 2015 Jun; 19(3):436-42. PubMed ID: 25059227
[TBL] [Abstract][Full Text] [Related]
18. The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study.
Yalçinkaya F; Cakar N; Acar B; Tutar E; Güriz H; Elhan AH; Oztürk S; Kansu A; Ince E; Atalay S; Girgin N; Doğru U; Aysev D; Ekim M
Rheumatol Int; 2007 Apr; 27(6):517-22. PubMed ID: 17103173
[TBL] [Abstract][Full Text] [Related]
19. Arg753Gln TLR-2 polymorphism in familial mediterranean fever: linking the environment to the phenotype in a monogenic inflammatory disease.
Ozen S; Berdeli A; Türel B; Kutlay S; Yalcinkaya F; Arici M; Besbas N; Bakkaloglu A; Yilmaz E
J Rheumatol; 2006 Dec; 33(12):2498-500. PubMed ID: 17013994
[TBL] [Abstract][Full Text] [Related]
20. P-wave dispersion in systemic AA amyloidosis of familial Mediterranean fever.
Nussinovitch U; Livneh A; Nussinovitch M; Volovitz B; Ben-Zvi I; Lidar M; Nussinovitch N
Clin Rheumatol; 2011 Oct; 30(10):1295-8. PubMed ID: 21484223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
